From the Department of Gynecology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Department of Gynecology, The First Affiliated Hospital of Hunan University of Medicine, Huaihua, Hunan, China.
Menopause. 2023 Dec 1;30(12):1206-1212. doi: 10.1097/GME.0000000000002271. Epub 2023 Oct 31.
To identify the optimal triage procedure for endometrial biopsies in postmenopausal women.
The clinical information of 470 postmenopausal women with endometrial biopsy results and postmenopausal bleeding (PMB) and/or transvaginal ultrasonography (TVU) abnormalities were collected at the gynecology departments of four general hospitals from March 2021 to March 2022. In the validation cohort, 112 women with TVU abnormalities who underwent endometrial biopsy at Xiangya hospital between May 2022 and May 2023 were enrolled. The endpoint was the final diagnosis based on hysteroscopy reports and biopsy pathology results. The sensitivity, specificity, positive predictive value, and negative predictive value were compared among the three triage methods. A nomogram prediction model was developed and validated.
Referring women with TVU abnormalities for endometrial biopsy identified 100% malignant/premalignant lesions despite low specificity (19.7%). Among women with measurable endometrial thickness (ET), we suggest that the ET cutoff value for biopsy referral should be ≥4 mm. The PMB (odds ratio [OR], 3.241; 95% confidence interval [CI], 1.073-9.789), diabetes (OR, 10.915; 95% CI, 3.389-35.156), and endometrial thickness (OR, 1.277; 95% CI, 1.156-1.409) were independent predictive factors for endometrial (pre)malignancy. A nomogram prediction model was constructed (area under curve [AUC] = 0.802, 95% CI: 0.715 to 0.889). The ideal cutoff point was 22.5, with a sensitivity of 100.0% and a specificity of 15.7%. The external validation achieved an AUC of 0.798 (95% CI, 0.685-0.911).
It was possible to refer all postmenopausal women with TVU abnormity (ET ≥ 4 mm or other abnormal findings) for endometrial biopsy. Among women with TVU abnormalities, a nomogram was constructed, and a score greater than 22.5 suggested the need for referral for endometrial biopsy, while a score less than 22.5 suggested that regular follow-up was required, further improving the triage procedure.
确定绝经后妇女子宫内膜活检的最佳分诊程序。
收集 2021 年 3 月至 2022 年 3 月四家综合医院妇科就诊的 470 例绝经后伴子宫内膜活检结果和(或)绝经后出血(PMB)和/或经阴道超声(TVU)异常的绝经后妇女的临床资料。在验证队列中,纳入 2022 年 5 月至 2023 年 5 月在湘雅医院因 TVU 异常接受子宫内膜活检的 112 例女性。终点是根据宫腔镜报告和活检病理结果的最终诊断。比较三种分诊方法的灵敏度、特异度、阳性预测值和阴性预测值。建立并验证列线图预测模型。
尽管特异性低(19.7%),但对 TVU 异常的女性进行子宫内膜活检可发现 100%的恶性/癌前病变。对于有可测量子宫内膜厚度(ET)的女性,我们建议活检转诊的 ET 截断值应≥4mm。PMB(比值比[OR],3.241;95%置信区间[CI],1.073-9.789)、糖尿病(OR,10.915;95%CI,3.389-35.156)和子宫内膜厚度(OR,1.277;95%CI,1.156-1.409)是子宫内膜(前)恶性肿瘤的独立预测因素。建立了列线图预测模型(曲线下面积[AUC]为 0.802,95%CI:0.715-0.889)。理想的截断点为 22.5,灵敏度为 100.0%,特异度为 15.7%。外部验证的 AUC 为 0.798(95%CI,0.685-0.911)。
对所有 TVU 异常(ET≥4mm 或其他异常发现)的绝经后妇女均可行子宫内膜活检。对于 TVU 异常的女性,建立了列线图,评分大于 22.5 提示需要转诊行子宫内膜活检,而评分小于 22.5 提示需要定期随访,进一步完善了分诊流程。